Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zongbao Ding

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Medicinal Chemistry|February 3, 2026
Discovery of potent bifunctional small molecules targeting DNA-PK and HDAC6 with desirable pharmacokinetic properties for acute myeloid leukemia treatmentZongbao Ding, Xiaoqing Zhao, Binbin Cheng, et al.
Frontiers in Chemistry|October 6, 2022
Grandiflolines A-F, new anti-inflammatory diterpenoid alkaloids isolated from <i>Delphinium grandiflorum</i>Yuanfeng Yan, Hongjun Jiang, Xiaoyan Yang, et al.
European Journal of Medicinal Chemistry|April 25, 2022
Discovery of novel 7,8-dihydropteridine-6(5H)-one-based DNA-PK inhibitors as potential anticancer agents via scaffold hopping strategyZongbao Ding, Wei Pan, Yao Xiao, et al.
Journal of Medicinal Chemistry|July 21, 2023
Discovery of Novel d-(+)-Biotin-Conjugated Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors for Targeted Cancer ImmunotherapyZongbao Ding, Shuanghu Wang, Yaru Shi, et al.
Journal of Medicinal Chemistry|April 25, 2024
Recent Progress in DNA Damage Response-Targeting PROTAC DegradersBinbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
European Journal of Medicinal Chemistry|February 5, 2025
Research progress in DNA damage response (DDR)-targeting modulators: From hits to clinical candidatesBinbin Cheng, Zongbao Ding, Yimeng Hong, et al.
European Journal of Medicinal Chemistry|January 11, 2024
HDAC-targeting epigenetic modulators for cancer immunotherapyBinbin Cheng, Wei Pan, Yao Xiao, et al.
Pharmacological Research|September 20, 2019
IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shockLei Tao, Yiyuan Wang, Jialan Xu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 21, 2021
Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destructionWende Deng, Zongbao Ding, Yiyuan Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 30, 2020
Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca<sup>2+</sup>-NFATc1 and Cav-1 signaling pathwaysBinhua Zou, Jiehuang Zheng, Wende Deng, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Medicinal Chemistry|February 3, 2026
Discovery of potent bifunctional small molecules targeting DNA-PK and HDAC6 with desirable pharmacokinetic properties for acute myeloid leukemia treatmentZongbao Ding, Xiaoqing Zhao, Binbin Cheng, et al.
Frontiers in Chemistry|October 6, 2022
Grandiflolines A-F, new anti-inflammatory diterpenoid alkaloids isolated from <i>Delphinium grandiflorum</i>Yuanfeng Yan, Hongjun Jiang, Xiaoyan Yang, et al.
European Journal of Medicinal Chemistry|April 25, 2022
Discovery of novel 7,8-dihydropteridine-6(5H)-one-based DNA-PK inhibitors as potential anticancer agents via scaffold hopping strategyZongbao Ding, Wei Pan, Yao Xiao, et al.
Journal of Medicinal Chemistry|July 21, 2023
Discovery of Novel d-(+)-Biotin-Conjugated Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors for Targeted Cancer ImmunotherapyZongbao Ding, Shuanghu Wang, Yaru Shi, et al.
Journal of Medicinal Chemistry|April 25, 2024
Recent Progress in DNA Damage Response-Targeting PROTAC DegradersBinbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
European Journal of Medicinal Chemistry|February 5, 2025
Research progress in DNA damage response (DDR)-targeting modulators: From hits to clinical candidatesBinbin Cheng, Zongbao Ding, Yimeng Hong, et al.
European Journal of Medicinal Chemistry|January 11, 2024
HDAC-targeting epigenetic modulators for cancer immunotherapyBinbin Cheng, Wei Pan, Yao Xiao, et al.
Pharmacological Research|September 20, 2019
IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shockLei Tao, Yiyuan Wang, Jialan Xu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 21, 2021
Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destructionWende Deng, Zongbao Ding, Yiyuan Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 30, 2020
Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca<sup>2+</sup>-NFATc1 and Cav-1 signaling pathwaysBinhua Zou, Jiehuang Zheng, Wende Deng, et al.
Pageof 2